Cargando…

Treatment of Type 2 Diabetes and Outcomes in Patients With Heart Failure: A Nested Case–Control Study From the U.K. General Practice Research Database

OBJECTIVE: Diabetes and heart failure commonly coexist, and prior studies have suggested better outcomes with metformin than other antidiabetic agents. We designed this study to determine whether this association reflects a beneficial effect of metformin or a harmful effect of other agents. RESEARCH...

Descripción completa

Detalles Bibliográficos
Autores principales:	MacDonald, Michael R., Eurich, Dean T., Majumdar, Sumit R., Lewsey, James D., Bhagra, Sai, Jhund, Pardeep S., Petrie, Mark C., McMurray, John J.V., Petrie, John R., McAlister, Finlay A.
Formato:	Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2010
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2875425/ https://www.ncbi.nlm.nih.gov/pubmed/20299488 http://dx.doi.org/10.2337/dc09-2227

Ejemplares similares

Changes in labelling for metformin use in patients with type 2 diabetes and heart failure: documented safety outweighs theoretical risks
por: Eurich, Dean T, et al.
Publicado: (2011)

Efficacy of implantable haemodynamic monitoring in heart failure across ranges of ejection fraction: a systematic review and meta-analysis
por: Curtain, James P, et al.
Publicado: (2023)

Analyzing composite outcomes in cardiovascular studies: traditional Cox proportional hazards versus quality-of-life–adjusted survival approaches
por: Eurich, Dean T, et al.
Publicado: (2010)

Drug therapy for heart failure with reduced ejection fraction: what is the ‘right’ dose?
por: Kondo, Toru, et al.
Publicado: (2022)

Association is not causation: treatment effects cannot be estimated from observational data in heart failure
por: Rush, Christopher J, et al.
Publicado: (2018)

Metformin treatment in diabetes and heart failure: when academic equipoise meets clinical reality
por: Eurich, Dean T, et al.
Publicado: (2009)

Treated glycosylated hemoglobin levels in individuals with diabetes mellitus vary little by health status: A retrospective cohort study
por: McAlister, Finlay A., et al.
Publicado: (2016)

Cost‐effectiveness of dapagliflozin as a treatment for heart failure with reduced ejection fraction: a multinational health‐economic analysis of DAPA‐HF
por: McEwan, Phil, et al.
Publicado: (2020)

A cluster randomized trial to assess the impact of opinion leader endorsed evidence summaries on improving quality of prescribing for patients with chronic cardiovascular disease: rationale and design [ISRCTN26365328]
por: Majumdar, Sumit R, et al.
Publicado: (2005)

Efficacy of an implantable cardioverter-defibrillator in patients with diabetes and heart failure and reduced ejection fraction
por: Rørth, Rasmus, et al.
Publicado: (2019)

Adverse Outcomes Associated With Interleukin-6 in Patients Recently Hospitalized for Heart Failure With Preserved Ejection Fraction
por: Mooney, Leanne, et al.
Publicado: (2023)

Mineralocorticoid Receptor Antagonists, Blood Pressure, and Outcomes in Heart Failure With Reduced Ejection Fraction
por: Serenelli, Matteo, et al.
Publicado: (2020)

Talking to patients with heart failure about end of life
por: Campbell, Ross T., et al.
Publicado: (2018)

The neprilysin pathway in heart failure: a review and guide on the use of sacubitril/valsartan
por: Jhund, Pardeep S, et al.
Publicado: (2016)

Estimating the Lifetime Benefits of Treatments for Heart Failure
por: Ferreira, João Pedro, et al.
Publicado: (2020)

Temporal trends in hospitalisation for stroke recurrence following incident hospitalisation for stroke in Scotland
por: Lewsey, James, et al.
Publicado: (2010)

Depressive symptoms are associated with higher rates of readmission or mortality after medical hospitalization: A systematic review and meta‐analysis
por: Pederson, Jenelle L., et al.
Publicado: (2016)

Initiation of domiciliary care and nursing home admission following first hospitalization of heart failure patients: a nationwide cohort study
por: Rørth, Rasmus, et al.
Publicado: (2018)

Cardiovascular medication utilization and adherence among adults living in rural and urban areas: a systematic review and meta-analysis
por: Murphy, Gaetanne K, et al.
Publicado: (2014)

Rationale and methods of a randomized trial evaluating the effect of neprilysin inhibition on left ventricular remodelling
por: Docherty, Kieran F., et al.
Publicado: (2020)

Temporal trends and risk factors for readmission for infections, gastrointestinal and immobility complications after an incident hospitalisation for stroke in Scotland between 1997 and 2005
por: Lewsey, James, et al.
Publicado: (2015)

Which patients with heart failure should receive specialist palliative care?
por: Campbell, Ross T., et al.
Publicado: (2018)

How Evidence-Based Are the Recommendations in Evidence-Based Guidelines?
por: McAlister, Finlay A, et al.
Publicado: (2007)

Trends in incidence and in short term survival following a subarachnoid haemorrhage in Scotland, 1986 - 2005: a retrospective cohort study
por: Macpherson, Karen J, et al.
Publicado: (2011)

Laboratory testing in newly treated elderly hypertensive patients without co-morbidities: a population-based cohort study
por: McAlister, Finlay Aleck, et al.
Publicado: (2007)

What can we learn from RELAX-AHF compared to previous AHF trials and what does the future hold?
por: Cannon, Jane A, et al.
Publicado: (2015)

Personalized medicine and hospitalization for heart failure: if we understand it, we may be successful in treating it
por: Ahmad, Faheem A., et al.
Publicado: (2019)

The preventing recurrent vascular events and neurological worsening through intensive organized case-management (PREVENTION) trial protocol [clinicaltrials.gov identifier: NCT00931788]
por: McAlister, Finlay A, et al.
Publicado: (2010)

Joint modelling of longitudinal processes and time-to-event outcomes in heart failure: systematic review and exemplar examining the relationship between serum digoxin levels and mortality
por: Field, Ryan J., et al.
Publicado: (2023)

Within trial comparison of survival time projections from short‐term follow‐up with long‐term follow‐up findings
por: Ferreira, João Pedro, et al.
Publicado: (2022)

Anthropometric measures and adverse outcomes in heart failure with reduced ejection fraction: revisiting the obesity paradox
por: Butt, Jawad H, et al.
Publicado: (2023)

Incidence of Hospitalization for Heart Failure and Case-Fatality Among 3.25 Million People With and Without Diabetes Mellitus
por: McAllister, David A., et al.
Publicado: (2018)

Initiation of Medical Therapy for Heart Failure Patients According to Kidney Function: A Danish Nationwide Study
por: Zahir Anjum, Deewa, et al.
Publicado: (2023)

The Dapagliflozin and Prevention of Adverse outcomes in Heart Failure trial (DAPA-HF) in context
por: McMurray, John J V, et al.
Publicado: (2020)

Virtual care and emergency department use
por: McAlister, Finlay A.
Publicado: (2023)

Effect of sacubitril/valsartan on investigator‐reported ventricular arrhythmias in PARADIGM‐HF
por: Curtain, James P., et al.
Publicado: (2022)

High-dose intravenous iron reduces myocardial infarction in patients on haemodialysis
por: Petrie, Mark C, et al.
Publicado: (2021)

Population-based cohort study of outpatients with pneumonia: rationale, design and baseline characteristics
por: Eurich, Dean T, et al.
Publicado: (2012)

Effect of Empagliflozin on Left Ventricular Volumes in Patients With Type 2 Diabetes, or Prediabetes, and Heart Failure With Reduced Ejection Fraction (SUGAR-DM-HF)
por: Lee, Matthew M.Y., et al.
Publicado: (2020)

Heart failure and atrial flutter: a systematic review of current knowledge and practices
por: Diamant, Michael J., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_lr3oi4s4ics412t8f6cfd66e7i